Regadenoson

Mfr.No.	T2671
Description	Regadenoson (CVT-3146) is an adenosine derivative and selective A2A adenosine receptor agonist with coronary vasodilating activity. Upon administration, regadenoson selectively binds to and activates the A2A adenosine receptor, which induces coronary vasodilation. This leads to an increase in coronary blood flow and enhances myocardial perfusion. Compared to adenosine, regadenoson has a longer half-life and shows higher selectivity towards the A2A adenosine receptor. This agent is a very weak agonist for the A1 adenosine receptor and has negligible affinity for the A2B and A3 adenosine receptors.
Alternative Names	CVT-3146
Molecular Formula	C15H18N8O5
Signaling Pathways	Neuroscience, GPCR/G Protein
Smiles	NC1=C2C(N(C=N2)(CH)3O(CH)(CO)(CH)(O)(CH)3O)=NC(=N1)N4C=C(C(NC)=O)C=N4
Cas Number	313348-27-5
Molecular Weight	390.35
Target	Adenosine Receptor

Have you used this product?

SKU	Supplier No.	Size	Your price
BHB20416586	T2671	1 mL	$66	Add to Cart
BHB20416586	T2671	2 mg	$39	Add to Cart
BHB20416586	T2671	5 mg	$59	Add to Cart
BHB20416586	T2671	10 mg	$93	Add to Cart
BHB20416586	T2671	25 mg	$183	Add to Cart
BHB20416586	T2671	50 mg	$287	Add to Cart
BHB20416586	T2671	100 mg	$438	Add to Cart
BHB20416586	T2671	500 mg	$985	Add to Cart